522 related articles for article (PubMed ID: 1807799)
41. Initiation of antiretroviral therapy in advanced AIDS with active tuberculosis: clinical experiences from Thailand.
Sungkanuparph S; Manosuthi W; Kiertiburanakul S; Vibhagool A
J Infect; 2006 Mar; 52(3):188-94. PubMed ID: 15992932
[TBL] [Abstract][Full Text] [Related]
42. Tuberculosis in patients infected with human immunodeficiency virus 1. A retrospective multicentre study of 123 cases in France. The Groupe des Infectiologues du Sud de la France.
Dupon M; Ragnaud JM
Q J Med; 1992 Oct; 85(306):719-30. PubMed ID: 1287704
[TBL] [Abstract][Full Text] [Related]
43. Global guidelines for treatment of tuberculosis among persons living with HIV: unresolved issues.
Kumar A; Kumar AM; Gupta D; Kanchar A; Mohammed S; Srinath S; Tripathy S; Rajasekaran S; Chan PL; Swaminathan S; Dewan PK
Int J Tuberc Lung Dis; 2012 May; 16(5):573-8. PubMed ID: 22507931
[TBL] [Abstract][Full Text] [Related]
44. The re-emergence of tuberculosis.
Porter JD; McAdam KP
Annu Rev Public Health; 1994; 15():303-23. PubMed ID: 8054087
[TBL] [Abstract][Full Text] [Related]
45. The point of view of a high prevalence country: Malawi.
Nyangulu DS
Bull Int Union Tuberc Lung Dis; 1991 Dec; 66(4):173-4. PubMed ID: 1687509
[TBL] [Abstract][Full Text] [Related]
46. Tuberculosis control and research strategies for the 1990s: memorandum from a WHO meeting.
Bull World Health Organ; 1992; 70(1):17-21. PubMed ID: 1568278
[TBL] [Abstract][Full Text] [Related]
47. HIV-associated tuberculosis: clinical update.
Swaminathan S; Padmapriyadarsini C; Narendran G
Clin Infect Dis; 2010 May; 50(10):1377-86. PubMed ID: 20388036
[TBL] [Abstract][Full Text] [Related]
48. HIV-associated tuberculosis in developing countries: epidemiology and strategies for prevention.
Narain JP; Raviglione MC; Kochi A
Tuber Lung Dis; 1992 Dec; 73(6):311-21. PubMed ID: 1292709
[TBL] [Abstract][Full Text] [Related]
49. HIV testing and treatment among tuberculosis patients --- Kenya, 2006-2009.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2010 Nov; 59(46):1514-7. PubMed ID: 21102405
[TBL] [Abstract][Full Text] [Related]
50. Drug prescribing practices for tuberculosis in Uzbekistan.
Hasker E; Khodjikhanov M; Usarova S; Asamidinov U; Yuldashova U; van der Werf MJ; Uzakova G; Veen J
Int J Tuberc Lung Dis; 2009 Nov; 13(11):1405-10. PubMed ID: 19861014
[TBL] [Abstract][Full Text] [Related]
51. Tuberculosis and immigrants: a SIMIT (Italian Society of Infectious Diseases) clinical, epidemiological multicentric research investigation.
Scotto G; Fornabaio C; Prato R; Saracino A; Tartaglia A; Di Tullio R; Carbonara S; Angarano G;
New Microbiol; 2009 Jan; 32(1):39-47. PubMed ID: 19382668
[TBL] [Abstract][Full Text] [Related]
52. Tuberculosis in children: treatment evaluation and results in a 5 year cohort of children with tuberculosis in Turiani Hospital, Tanzania.
Van den Hombergh J; Gebhard AC; Voorhoeve HW
East Afr Med J; 1991 Sep; 68(9):686-93. PubMed ID: 1724647
[TBL] [Abstract][Full Text] [Related]
53. Adherence with isoniazid for prevention of tuberculosis among HIV-infected adults in South Africa.
Szakacs TA; Wilson D; Cameron DW; Clark M; Kocheleff P; Muller FJ; McCarthy AE
BMC Infect Dis; 2006 Jun; 6():97. PubMed ID: 16772037
[TBL] [Abstract][Full Text] [Related]
54. Toward an optimized therapy for tuberculosis? Drugs in clinical trials and in preclinical development.
Ma Z; Lienhardt C
Clin Chest Med; 2009 Dec; 30(4):755-68, ix. PubMed ID: 19925965
[TBL] [Abstract][Full Text] [Related]
55. Human immunodeficiency virus and tuberculosis coinfection in children: challenges in diagnosis and treatment.
Verhagen LM; Warris A; van Soolingen D; de Groot R; Hermans PW
Pediatr Infect Dis J; 2010 Oct; 29(10):e63-70. PubMed ID: 20651637
[TBL] [Abstract][Full Text] [Related]
56. The impact of HIV on resource utilization by patients with tuberculosis in a tertiary referral hospital, Nairobi, Kenya.
Nunn P; Gathua S; Kibuga D; Binge R; Brindle R; Odhiambo J; McAdam K
Tuber Lung Dis; 1993 Aug; 74(4):273-9. PubMed ID: 8219180
[TBL] [Abstract][Full Text] [Related]
57. Tuberculosis control in resource-poor countries: alternative approaches in the era of HIV.
De Cock KM; Wilkinson D
Lancet; 1995 Sep; 346(8976):675-7. PubMed ID: 7658822
[TBL] [Abstract][Full Text] [Related]
58. Potential utility of empirical tuberculosis treatment for HIV-infected patients with advanced immunodeficiency in high TB-HIV burden settings.
Lawn SD; Ayles H; Egwaga S; Williams B; Mukadi YD; Santos Filho ED; Godfrey-Faussett P; Granich RM; Harries AD
Int J Tuberc Lung Dis; 2011 Mar; 15(3):287-95. PubMed ID: 21333094
[TBL] [Abstract][Full Text] [Related]
59. Tuberculosis and HIV coinfection.
Gray JM; Cohn DL
Semin Respir Crit Care Med; 2013 Feb; 34(1):32-43. PubMed ID: 23460004
[TBL] [Abstract][Full Text] [Related]
60. Patient costs of accessing collaborative tuberculosis and human immunodeficiency virus interventions in Ethiopia.
Vassall A; Seme A; Compernolle P; Meheus F
Int J Tuberc Lung Dis; 2010 May; 14(5):604-10. PubMed ID: 20392354
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
